Vyome Holdings, Inc
HIND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427570
No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Vyome Holdings, Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −13 vs. Q3 2022
- Shares held
- 1.69K
- −793.8K (−99.8%) vs. Q3 2022
- Total value
- $12.2K
- −$224.8K (−94.9%) vs. Q3 2022
- New holders
- 2
- 0 more added
- Sold out
- 15
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HIND on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $296.5K |
| Q1 2026 | 9 | $198.3K |
| Q4 2025 | 8 | $322.3K |
| Q3 2025 | 5 | $125.4K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $1 |
| Q4 2024 | 1 | $13 |
| Q3 2024 | 2 | $24 |
| Q2 2024 | 16 | $73.3K |
| Q1 2024 | 18 | $49.1K |
| Q4 2023 | 15 | $108.3K |
| Q3 2023 | 17 | $134.7K |
| Q2 2023 | 11 | $153.5K |
| Q1 2023 | 13 | $370.3K |
| Q4 2022 | 10 | $12.2K |
| Q3 2022 | 23 | $237.0K |
| Q2 2022 | 19 | $744.0K |
| Q1 2022 | 17 | $1.45M |
| Q4 2021 | 15 | $1.91M |
| Q3 2021 | 18 | $1.90M |
| Q2 2021 | 15 | $5.23M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Vyome Holdings, Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 5 | $0 | 0.00% | −3,954−99.9% | Reduced |
| JPMorgan Chase & Co | 1 | $0 | 0.00% | +1 | New |
| Morgan Stanley | 1 | $7 | 0.00% | −79−98.8% | Reduced |
| Wells Fargo & Company | 3 | $20 | 0.00% | −145−98.0% | Reduced |
| Group One Trading, L.P. | 3 | $20 | 0.00% | −109−97.3% | Reduced |
| BlackRock Inc. | 17 | $115 | 0.00% | −880−98.1% | Reduced |
| Cornerstone Planning Group LLC | 35 | $252 | 0.00% | +35 | New |
| Transamerica Financial Advisors, Inc. | 2 | $1.00K | 0.00% | −73−97.3% | Reduced |
| UBS Group AG | 264 | $1.78K | 0.00% | −1,026−79.5% | Reduced |
| Tower Research Capital LLC (TRC) | 1,357 | $9.00K | 0.00% | −30,878−95.8% | Reduced |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −306,611−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −118,607−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −55,887−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −52,180−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −36,100−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −33,426−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −32,883−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −30,200−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −20,700−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −20,294−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −14,343−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −13,958−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,702−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,791−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −1−100.0% | Sold out |